- Home
- CMMB vs TOMZ Comparison
CMMB vs TOMZ Comparison
Compare CMMB & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMMB | TOMZ |
|---|---|---|
| Founded | 2004 | 1979 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 12.5M |
| IPO Year | 2023 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CMMB | TOMZ |
|---|---|---|
| Price | $2.25 | $0.81 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 104.3K | ★ 192.0K |
| Earning Date | 05-21-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | 13.64 |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | ★ $5,635,927.00 |
| Revenue This Year | N/A | $48.56 |
| Revenue Next Year | N/A | $121.37 |
| P/E Ratio | $56.75 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.87 | $0.50 |
| 52 Week High | $3.86 | $1.20 |
Technical Indicators
Market Signals| Indicator | CMMB | TOMZ |
|---|---|---|
| Relative Strength Index (RSI) | 74.41 | 52.91 |
| Support Level | $1.48 | $0.69 |
| Resistance Level | $2.80 | $1.11 |
| Average True Range (ATR) | 0.17 | 0.09 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 84.04 | 67.78 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.